⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
accessnewswire.com
MRK
Global Nasal Sprays Market to Reach USD 29.7 Billion by 2036, Driven by Rising Allergy Cases and Non-Oral Drug Demand
prnewswire.com
GSK
JNJ
NVS
AZN
PFE
MRK
SNY
Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
globenewswire.com
MRK
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
globenewswire.com
MRK
Ray Therapeutics Announces Upsized and Oversubscribed $125 Million Series B Financing for Vision Restoration Treatments
businesswire.com
JHG
BEN
MRK
Immuno-Oncology Drugs Market Opportunity Analysis and Forecast Report 2026-2035: Merck & Co. Remains a Dominant Force, Supported by the Commercial Success of Keytruda
globenewswire.com
MRK
BMY
GILD
TAK
Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights
globenewswire.com
MRK
BMY
AMGN
REPL
Trispecific Antibodies Market Landscape Report 2026: Opportunity and Proprietary Insights - 90 Trispecific Antibodies by Company, Country, Indication & Phase
globenewswire.com
MRK
JNJ
ABBV
OPK
Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge
globenewswire.com
AZN
MRK
BMY
PFE
AMGN
Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR
globenewswire.com
TMO
MRK
GEHC
AZN